3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with Brain Damage, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, R; Chen, MH; Graham, DI; Inglis, FM; McCulloch, J; Miller, JD | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Brain Damage, Chronic
Article | Year |
---|---|
Ischaemic brain damage associated with tissue hypermetabolism in acute subdural haematoma: reduction by a glutamate antagonist.
Topics: Acute Disease; Animals; Autoradiography; Brain; Brain Damage, Chronic; Brain Ischemia; Cerebrovascular Circulation; Excitatory Amino Acid Antagonists; Glutamic Acid; Hematoma, Subdural; Male; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1990 |